HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Bosly Selected Research

LNH87-2 protocol

8/2000Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Bosly Research Topics

Disease

9Lymphoma (Lymphomas)
04/2010 - 03/2000
6Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2001 - 06/2000
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
12/2005 - 03/2000
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
04/2008 - 06/2005
2Neoplasms (Cancer)
06/2006 - 10/2004
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
07/2010
1Genetic Translocation (Chromosomal Translocation)
10/2004
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
10/2004
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2004
1Enteropathy-Associated T-Cell Lymphoma
05/2004
1Residual Neoplasm
09/2001
1Cytopenia
08/2001
1Hematologic Neoplasms (Hematological Malignancy)
03/2001
1Hodgkin Disease (Hodgkin's Disease)
03/2001
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
06/2000

Drug/Important Bio-Agent (IBA)

5Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2008 - 03/2000
3Prednisone (Sone)FDA LinkGeneric
04/2008 - 03/2000
3Doxorubicin (Adriamycin)FDA LinkGeneric
04/2008 - 03/2000
3DecitabineFDA Link
12/2005 - 03/2000
2Imatinib Mesylate (Gleevec)FDA Link
07/2010 - 10/2004
2Methotrexate (Mexate)FDA LinkGeneric
04/2010 - 03/2000
2Vincristine (Oncovin)FDA LinkGeneric
04/2008 - 06/2005
2Bleomycin (Blenoxane)FDA LinkGeneric
04/2008 - 03/2000
2Vindesine (Vindesin)IBA
04/2008 - 03/2000
2Rituximab (Mabthera)FDA Link
06/2005 - 02/2004
2Etoposide (VP 16)FDA LinkGeneric
08/2000 - 03/2000
1nilotinibFDA Link
07/2010
1Dasatinib (BMS 354825)FDA Link
07/2010
1Teniposide (VM 26)FDA Link
04/2008
1Tyrosine (L-Tyrosine)FDA Link
10/2004
1Transcription Factors (Transcription Factor)IBA
10/2004
1Phosphotransferases (Kinase)IBA
10/2004
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2004
1Glutens (Glutelin)IBA
05/2004
12-Hydroxypropyl-beta-cyclodextrinIBA
03/2001
1Itraconazole (Sporanox)FDA LinkGeneric
03/2001
1SolutionsIBA
03/2001
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2000
1Carmustine (FIVB)FDA Link
08/2000
1Cytarabine (Cytosar-U)FDA LinkGeneric
08/2000
1IfosfamideFDA LinkGeneric
08/2000
1Asparaginase (Elspar)FDA Link
08/2000
1CladribineFDA LinkGeneric
06/2000
1A-Form DNA (A-DNA)IBA
03/2000

Therapy/Procedure

9Drug Therapy (Chemotherapy)
04/2010 - 08/2000
5Therapeutics
07/2010 - 03/2000
2Radiotherapy
04/2010 - 09/2001
2Autologous Transplantation
09/2001 - 09/2000
1CHVP protocol
04/2008
1Patient Admission (Patient Admissions)
06/2006
1Immunotherapy
09/2001
1LNH 87 protocol
03/2001
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
09/2000
1LNH87-2 protocol
08/2000
1Stem Cell Transplantation
08/2000